Amphastar Pharmaceuticals Inc

AMPH

Company Profile

  • Business description

    Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

  • Contact

    11570 6th Street
    Rancho CucamongaCA91730
    USA

    T: +1 909 980-9484

    https://www.amphastar.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,976

Stocks News & Analysis

stocks

ASX miner weathers the storm with strong commodity prices

Lower volumes due cyclone activity but revenues hold steady.
stocks

Eli Lilly earnings: Mounjaro/Zepbound’s massive volume growth more than counters price pressure

We’ve raised our fair value estimate of Lilly stock.
stocks

OpenAI missed multiple revenue targets - here’s why it likely won’t IPO this year

Plus, whichever AI company IPOs first defines what “good” looks like.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,954.7021.20-0.24%
CAC 408,114.840.000.00%
DAX 4024,292.38337.821.41%
Dow JONES (US)49,499.27152.87-0.31%
FTSE 10010,363.9314.89-0.14%
HKSE25,776.53335.31-1.28%
NASDAQ25,114.44222.130.89%
Nikkei 22559,513.12228.200.38%
NZX 50 Index13,039.20135.891.05%
S&P 5007,230.1221.110.29%
S&P/ASX 2008,729.8021.20-0.24%
SSE Composite Index4,112.164.650.11%

Market Movers